Abstract Aquaporin-3 (AQP3) is a water/glycerol transporting protein expressed strongly at the plasma membrane of keratinocytes. There is evidence for involvement of AQP3-facilitated water and glycerol transport in keratinocyte migration and proliferation, respectively. Here, we investigated the involvement of AQP3 in keratinocyte diVerentiation. Studies were done using AQP3 knockout mice, primary cultures of mouse keratinocytes (AQP3 knockout), neonatal human keratinocytes (AQP3 knockdown), and human skin. Cells were cultured with high Ca 2+ or 1 ,25-dihydroxyvitamin D 3 (VD 3 ) to induce diVerentiation. The expression of diVerentiation marker proteins and diVerentiating responses were comparable in control and AQP3-knockout or knockdown keratinocytes. Topical application of all-trans retinoic acid (RA), a known regulator of keratinocyte diVerentiation and proliferation, induced comparable expression of diVerentiation marker proteins in wildtype and AQP3 null epidermis, though with impaired RA-induced proliferation in AQP3 null mice. Immunostaining of human and mouse epidermis showed greater AQP3 expression in cells undergoing proliferation than diVerentiation. Our results showed little inXuence of AQP3 on keratinocyte diVerentiation, and provide further support for the proposed involvement of AQP3-facilitated cell proliferation.
Introduction
The aquaporins (AQPs) are a family of small, integral membrane proteins that transport water and in some cases small solutes such as glycerol, termed aquaglyceroporins (AQPs 3, 7 and 9) [14, 23] . Phenotype analysis of AQPs knockout mice has revealed multiple physiological roles of AQPs. AQP-facilitated water transport is involved in the urinary concentrating mechanism, epithelial Xuid secretion, brain edema, neural signal transduction, and cell migration [24] . Aquaglyceroporin-facilitated glycerol transport is involved in metabolic pathways, such as adipose AQP7 in obesity [10] and AQP9 in glycerol metabolism [19] .
In mammalian epidermis, AQP3 is strongly expressed in plasma membranes of keratinocytes [15, 21] . AQP3-deWcient mouse skin has reduced stratum corneum water content and elasticity compared to that of wildtype mice [8, 15] . These defects were found to result from deWciency of AQP3-facilitated glycerol transport, reducing stratum corneum and epidermal cell glycerol content and hence humectant properties [9] . Recent data implicated AQP3 function as a novel determinant in cutaneous wound healing and tumorigenesis. AQP3-facilitated water transport is involved in cell migration, accelerating wound healing [11] . AQP3-facilitated glycerol transport is involved in keratinocyte proliferation, in which AQP3 knockout mice are resistant to tumor formation by a mechanism that may involve reduced cell glycerol content and ATP energy for cell growth and tumorigenesis [12] .
A study using mouse primary cultured keratinocytes has also suggested the involvement of AQP3 in keratinocyte diVerentiation [3] . AQP3 overexpression increased the expression of diVerentiation markers, though decreased that of a proliferation marker. Phosphatidylglycerol (PG), which is involved in keratinocyte diVerentiation and thought to be produced by AQP3-mediated glycerol and phospholipase D2 (PLD2), inhibited DNA synthesis, suggesting a PLD2/AQP3 'signaling module' as a regulator of keratinocyte diVerentiation. Involvement of AQP3 in keratinocyte diVerentiation would represent a major new role of AQP3 in skin, with potentially broad consequences regarding normal epidermal diVerentiation and disease pathophysiology.
The aim of this study is to investigate the involvement of AQP3 in keratinocyte diVerentiation. We utilized AQP3 knockout mice and primary keratinocyte cultures derived therefrom, neonatal human keratinocytes (NHK) after AQP3 knockdown, and human skin. Keratinocyte diVerentiation was induced in cell cultures by treatments with Ca 2+ or VD 3 [2, 5] , and mouse skin was treated with all-trans retinoic acid (RA), a known regulator of keratinocyte diVerentiation and proliferation [6] . To assess keratinocyte diVerentiation, we measured the expression of diVerentiation marker proteins, corniWed cell envelope (CE) formation, and transglutaminase (TGase) activity. The data showed no eVect of AQP3 on keratinocyte diVerentiation markers or the response in each of these systems, providing strong evidence that keratinocyte diVerentiation does not depend on AQP3. Furthermore, immunostaining of mouse and human skin showed AQP3 expression in cells undergoing proliferation rather than diVerentiation, supporting the involvement of AQP3 in keratinocyte proliferation rather than diVerentiation.
Materials and methods

Mice
AQP3 null mice (hairless and CD1 genetic background) were generated by targeted gene disruption as described [16] . All animal experiments were approved by the Committee on Animal Research of Kyoto University. CE assay was performed as described [22] . BrieXy, cells were harvested by trypsinization, and 1 £ 10 5 cells were washed twice with phosphate-buVered saline (PBS) (pH 7.5) and treated with 50 l of 2% sodium dodecyl sulfate (SDS), containing 20 mM dithiothreitol (DTT), and then heat-treated for 5 min at 100°C. Detergent-and reducing agent-resistant CEs were counted in a hemocytometer under phase optics. TGase activity was measured by protein-bound Xuorescence after incorporation of monodansylcadaverine into casein (Sigma, St Louis, MO, USA) as described [17] .
Human keratinocyte cell cultures
Neonatal human keratinocytes (Kurabo industries Ltd, Osaka, Japan) were grown in keratinocyte growth medium containing 0.15 mM calcium (Cascade Biologics. Portland, OR, USA). NHK were transfected with AQP3 siRNA or RISC-free siRNA (Dharmacon, Lafayette, CO, USA) at 40-50% conXuence using Lipofectamine 2000™ (Invitrogen). To induce cell diVerentiation, keratinocytes were cultured in 1.5 mM calcium (high Ca) for 6 days after conXuence. AQP3 expression was assessed by immunoXuorecence using a polyclonal AQP3 antibody (Chemicon, Temecula, CA, USA, 1:200) and anti-rabbit Cy3-conjugated IgG secondary antibody (Sigma).
Retinoic acid-induced cell proliferation and diVerentiation in mouse epidermis Dorsal skin of mice was treated with four applications of all-trans retinoic acid (Sigma, 0.0125%, 100 l ethanol) or vehicle, and skin was excised at 24 h after Wnal treatment. For measurement of epidermal cell proliferation, mice were injected intraperitoneally with BrdU (100 g/g body weight; Sigma-Aldrich) at 1 h prior to sacriWce. ParaYnembedded sections were stained with hematoxylin and eosin, or anti-BrdU antibody (ABcam, Cambridge, MA, USA, 1:20) with biotinylated anti-rat IgG and HRP-conjugated ABC reagent (Vector Laboratories Inc.). BrdU positive cells were counted, with >200 basal cells examined per mouse.
For immunoblot analysis, epidermal sheets were separated from dermis by heat-split, and homogenized in lysis buVer including 0.1 M Tris hydroxymethyl aminomethaneHCl (pH 9), 6 M urea, 1% 2-mercaptoethanol, 1% SDS, 1 mM EDTA and 0.1 mM PMSF. The supernatant (10,000g, 10 min, 4°C) was used for immunoblotting as described below.
Immunoblot analysis
Keratinocytes were lysed and homogenated in cell lysis buVer (Cell Signaling Technology, Boston, MA, USA). The supernatant (10,000g, 10 min, 4°C) was used for immunoblotting with primary antibodies against involucrin (Covance for mice, Emeryville, CA, USA, 1:1,000; Abcam for human 1:1,000), Wlaggrin (Covance 1:1,000), loricrin (Covance 1:1,000), keratin 5 (Lab Vision, Fremont, CA, USA, 1:500), keratin 10 (Chemicon 1:1,000), keratin 14 (Chemicon 1:200) and -actin (Sigma 1:2,000). Horseradish peroxidase-conjugated secondary anti-rabbit IgG antibody (Cell Signaling Technology) or anti-mouse IgG antibody (DAKO, Carpinteria, CA, USA) was used for detection by enhanced chemiluminescence (Amersham Pharmacia, Piscataway, NJ, USA).
Immunostaining of human and mice skin
After receiving informed consent, we obtained abdominal skin samples from normal human adults undergoing plastic surgery. Tissues were Wxed in formalin for paraYn sectioning. After deparaYnization, section was treated in sodium citrate buVer (10 mM sodium citrate, pH 6.0) for 20 min at 95-100°C for antigen retrieval, and stained with anti-keratin 14 (Chemicon 1:10), keratin 10 (Chemicon 1:100), keratin 6 (Lab Vision 1:100) or AQP3 (Chemicon 1:200).
Statistical analysis
Statistical analysis was performed with a two-tailed indirect Student's t test or ANOVA.
Results
Comparable cell diVerentiation in control and AQP3-deWcient keratinocytes
To investigate if AQP3 gene deletion aVected keratinocyte diVerentiation, we used primary cultured keratinocytes from epidermis of wildtype and AQP3 null mice. Keratinocytes were cultured with low Ca 2+ (0.15 mM) until conXuence, and then treated with high Ca 2+ (1.5 mM) for 4 days or VD 3 for 3 days to induce diVerentiation. Involucrin, a marker of intermediate diVerentiation [5] , was increased with high Ca 2+ and VD 3 in both wildtype and AQP3 null keratinocyte (Fig. 1a) . Keratin 10, a marker of early diVerentiation, was also increased with high Ca 2+ . A decrease was found in keratin 5, a marker of basal proliferating cells, indicated suppressed proliferation in both wildtype and AQP3 null keratinocytes. Figure 1b shows (Fig. 1c, d) .
Keratinocyte diVerentiation was also studied in neonatal human keratinocytes (NHKs). To knockdown AQP3 expression, NHKs were transfected with siRNA-AQP3 or RISC-free siRNA at 40-50% conXuence, and then cultured in low Ca 2+ media until conXuence (low Ca 2+ ). To induce diVerentiation, NHKs were treated with 1.5 mM Ca 2+ medium for 6 days (high Ca 2+ ). Immunostaining assay conWrmed AQP3 expression in conXuent and high Ca 2+ -induced diVerentiated NHKs (Fig. 2a, upper) . Transfection of siRNA-AQP3 consistently reduced AQP3 protein expression by »95% (Fig. 2a, lower) . In this setting, diVerentiation markers were compared between control and AQP3 knocked down cells by immunobloting. We found no signiWcant diVerences in the increases of involucrin, loricrin and keratin 10, or the decrease in keratin 5 in high Ca 2+ treated control and AQP3 knockdown NHKs (Fig. 2b) . As summarized in Fig. 2c , comparable increases in diVerentiation markers were found in control and AQP3 knockdown NHKs, providing evidence against involvement of AQP3 in keratinocyte diVerentiation.
RA induces comparable epidermal diVerentiation in wildtype and AQP3 null skin
To investigate the role of AQP3 in keratinocyte diVerentiation and proliferation in vivo, dorsal skin of mice was topically treated with RA [6] . RA is potent stimulator of keratinocyte proliferation, which is mediated by heparinbinding epidermal growth factor-like growth factor [18, 25] . RA was also found to modulate diVerentiation, as seen as an increase in involucrin in vivo, consistent with our Wndings here, though it suppresses terminal diVerentiation in cultured cells [7, 20] . Figure 3a shows greater hyperplasia after four RA treatments in wildtype than in AQP3 null epidermis. To account for the diVerence in hyperplasia, epidermal cell proliferation was signiWcantly greater in wildtype mice than in AQP3 null mice, as shown by the greater percentage of BrdU positive epidermal cells following RA treatment (Fig. 3b) . To further study RA-mediated cell diVerentiation, the expressions of several diVerentiation marker proteins were examined by immunoblotting.
Despite the marked diVerences in the cell proliferation, RA treatment produced comparable expression in involucrin, loricrin and Wlaggrin between wildtype and AQP3 null epidermis, indicating comparable diVerentiation responses to RA application (Fig. 3c, upper) . RA altered the expression of keratin 5 and 14, which is likely related to the involvement of AQP3 in keratinocyte proliferation rather than diVerentiation (Fig. 3c, lower) . AQP3 is expressed more strongly in the basal than the upper layer of diVerentiated keratinocyte in mouse epidermis [15] . To further investigate the possible involvement of AQP3 in keratinocyte diVerentiation, AQP3 localization was examined in RA-treated epidermis. As shown in Fig. 3d , RA treatment increased AQP3 expression compared to control epidermis, and as found previously in human keratinocytes [1, 4] . AQP3 was found to be expressed not only in basal layer but also in the middle layer of epidermis in RA treated skin. Co-labeling with anti-keratin antibodies showed that AQP3 expression was greater in proliferating, keratin 14 positive cells, than in diVerentiating, keratin 10 positive cells (Fig. 3e) . AQP3 was also found to be expressed in keratin 6 positive cells, hyperproliferative cells, in the upper layer of RA treated epidermis. These in vivo experiments suggest that AQP3 facilitates keratinocyte proliferation rather than diVerentiation. Localization of AQP3 in normal human epidermis Last, we examined AQP3 localization in human skin from abdomen with normal structure (Fig. 4a) . As shown in Fig. 4b, AQP3 was expressed more strongly in basal and suprabasal layers than in upper layers of normal epidermis. Co-labeling showed greater AQP3 localization in keratin-14 positive cells, a marker of basal cell proliferation (Fig. 4b) . AQP3 was partly expressed in the lower part of keratin 10 and involucrin positive cell layer, early diVerentiating cells. These observations further support the involvement of AQP3 in cell proliferation rather than diVerentiation.
Discussion
We used several biochemical and immunohistochemical approaches to examine the involvement of AQP3 in keratinocyte diVerentiation. In all assays using diVerent systems, including genetically modiWed AQP3 null mice, we found no eVect of AQP3 expression on keratinocyte diVerentiation. First, we found no signiWcant diVerences in the expression patterns of diVerentiation marker proteins, CE formation, and TGase activity between keratinocytes from control and AQP3 deWcient mice during in vitro diVerentiation induced by high Ca 2+ -or VD 3 . Second, control and AQP3 knock-down human keratinocytes equally expressed diVerentiation markers upon high Ca 2+ -treatment. Third, RA-induced cell diVerentiation did not diVer in intact epidermis from wildtype and AQP3 null mice, though impaired cell proliferation was found in RA-treated AQP3 null epidermis. The impaired RA-mediated proliferation in AQP3 deWciency, with comparable diVerentiation, provides evidence that AQP3 is involved in proliferation, but not diVerentiation, during hyperproliferation. The data are consistent with previous results showing impaired mitogen induced cell proliferation in AQP3 deWcient keratinocyte following treatment with phorbol ester (TPA), EGF and wounding [11, 12] . Last, immunostaining of mouse and Our data do not support recent reports using mouse keratinocytes suggesting the requirement of AQP3 in keratinocyte diVerentiation. Zheng et al. [26] reported colocalization of AQP3 with phospholipase D2 (PLD2) in caveolin-rich membrane microdomains in keratinocytes. In a separate report, the same group found that glycerol was utilized by PLD2 to generate phosphatidylglycerol (PG), which was modulated by the diVerentiation agent high Ca 2+ , suggesting that PG is an important signaling lipid for keratinocyte diVerentiation [27] . A more recent study reported that inhibition of AQP3 glycerol transport by acidic medium reduced PG synthesis [3] . From these results the authors suggested that AQP3 participates with PLD2 in a glycerol-phosphotidylglycerol signalling module, which promote keratinocyte diVerentiation. They showed that AQP3 overexpression stimulated diVerentiation responses such as promoter activity of keratin 10 and involucrin. However, our present study utilizing multiple systems found no eVect of AQP3 expression on keratinocyte diVerentiation responses.
In conclusion, our data showed little involvement of AQP3 in keratinocyte diVerentiation. Our Wndings and previous studies [13] suggest that AQP3 plays an important role in keratinocyte proliferation and migration, rather than in diVerentiation, in epidermal homeostasis and skin disorders such as tumorigenesis and wound healing. Further work is needed to elucidate the precise mechanism of AQP3-mediated cell proliferation, which is likely of relevance to human skin disorders associated with epidermal hyperproliferation and inXammation.
